Scholarlink

<p>ABO-incompatible kidney transplantation (ABO-i KT) facilitates transplantation across blood types; however, antibody-mediated rejection (ABMR) remains a major concern, particularly in blood type O recipients. This retrospective study evaluated the effect of immunoglobulin G (IgG) monitoring and machine learning (ML)-based IgG prediction on post-transplant outcomes in 408 ABO-i KT recipients treated between 2014 and 2020. In blood type O recipients, the introduction of IgG monitoring (Era 2) was associated with a significantly lower incidence of ABMR (<i>P</i> = 0.041) and acute rejection (<i>P</i> = 0.037) compared with Immunoglobulin M (IgM)-only monitoring (Era 1). A higher initial IgM titer was identified as a risk factor for ABMR. To address the absence of IgG data in the IgM-only cohort, an ML model was developed using 610 cases to predict pre-transplant IgG titers based on IgM levels, number of plasmapheresis sessions, and ABO blood type. The model demonstrated good predictive performance (mean absolute error [MAE] = 0.593, R<sup>2</sup> = 0.721) and indicated that 12.2% of type O recipients in the IgM-only era were estimated to have high IgG titers (≥ 1:64). These findings support the clinical utility of IgG monitoring and ML-based estimation to enhance immunologic risk stratification and optimize preconditioning strategies in ABO-i KT.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Impact of IgG monitoring and machine learning based prediction on outcomes of ABO incompatible kidney transplantation in blood type O recipients

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年11月25日

查看全文
  • Youngmin Ko,
  • Jin-Myung Kim,
  • Hye Eun Kwon,
  • Sung Shin,
  • Joo Hee Jung,
  • Young Hoon Kim,
  • Juhan Lee,
  • Dae-Hyun Ko,
  • Hyunwook Kwon

摘要

ABO-incompatible kidney transplantation (ABO-i KT) facilitates transplantation across blood types; however, antibody-mediated rejection (ABMR) remains a major concern, particularly in blood type O recipients. This retrospective study evaluated the effect of immunoglobulin G (IgG) monitoring and machine learning (ML)-based IgG prediction on post-transplant outcomes in 408 ABO-i KT recipients treated between 2014 and 2020. In blood type O recipients, the introduction of IgG monitoring (Era 2) was associated with a significantly lower incidence of ABMR (P = 0.041) and acute rejection (P = 0.037) compared with Immunoglobulin M (IgM)-only monitoring (Era 1). A higher initial IgM titer was identified as a risk factor for ABMR. To address the absence of IgG data in the IgM-only cohort, an ML model was developed using 610 cases to predict pre-transplant IgG titers based on IgM levels, number of plasmapheresis sessions, and ABO blood type. The model demonstrated good predictive performance (mean absolute error [MAE] = 0.593, R2 = 0.721) and indicated that 12.2% of type O recipients in the IgM-only era were estimated to have high IgG titers (≥ 1:64). These findings support the clinical utility of IgG monitoring and ML-based estimation to enhance immunologic risk stratification and optimize preconditioning strategies in ABO-i KT.